Literature DB >> 23692563

Chemical tailoring of teicoplanin with site-selective reactions.

Tejas P Pathak1, Scott J Miller.   

Abstract

Semisynthesis of natural product derivatives combines the power of fermentation with orthogonal chemical reactions. Yet, chemical modification of complex structures represents an unmet challenge, as poor selectivity often undermines efficiency. The complex antibiotic teicoplanin eradicates bacterial infections. However, as resistance emerges, the demand for improved analogues grows. We have discovered chemical reactions that achieve site-selective alteration of teicoplanin. Utilizing peptide-based additives that alter reaction selectivities, certain bromo-teicoplanins are accessible. These new compounds are also scaffolds for selective cross-coupling reactions, enabling further molecular diversification. These studies enable two-step access to glycopeptide analogues not available through either biosynthesis or rapid total chemical synthesis alone. The new compounds exhibit a spectrum of activities, revealing that selective chemical alteration of teicoplanin may lead to analogues with attenuated or enhanced antibacterial properties, in particular against vancomycin- and teicoplanin-resistant strains.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23692563      PMCID: PMC3800266          DOI: 10.1021/ja4038998

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  37 in total

1.  Total synthesis of teicoplanin aglycon.

Authors:  D A Evans; J L Katz; G S Peterson; T Hintermann
Journal:  J Am Chem Soc       Date:  2001-12-12       Impact factor: 15.419

2.  Lewis base catalysis of bromo- and iodolactonization, and cycloetherification.

Authors:  Scott E Denmark; Matthew T Burk
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-12       Impact factor: 11.205

Review 3.  Glycopeptide and lipoglycopeptide antibiotics.

Authors:  Dan Kahne; Catherine Leimkuhler; Wei Lu; Christopher Walsh
Journal:  Chem Rev       Date:  2005-02       Impact factor: 60.622

Review 4.  Drugs for bad bugs: confronting the challenges of antibacterial discovery.

Authors:  David J Payne; Michael N Gwynn; David J Holmes; David L Pompliano
Journal:  Nat Rev Drug Discov       Date:  2006-12-08       Impact factor: 84.694

5.  Interception of teicoplanin oxidation intermediates yields new antimicrobial scaffolds.

Authors:  Yu-Chen Liu; Yi-Shan Li; Syue-Yi Lyu; Li-Jen Hsu; Yu-Hou Chen; Yu-Ting Huang; Hsiu-Chien Chan; Chuen-Jiuan Huang; Gan-Hong Chen; Chia-Cheng Chou; Ming-Daw Tsai; Tsung-Lin Li
Journal:  Nat Chem Biol       Date:  2011-04-10       Impact factor: 15.040

Review 6.  Combining biocatalysis and chemoselective chemistries for glycopeptide antibiotics modification.

Authors:  Tsung-Lin Li; Yu-Chen Liu; Syue-Yi Lyu
Journal:  Curr Opin Chem Biol       Date:  2012-02-13       Impact factor: 8.822

Review 7.  Origin, structure, and activity in vitro and in vivo of dalbavancin.

Authors:  Adriano Malabarba; Beth P Goldstein
Journal:  J Antimicrob Chemother       Date:  2005-03       Impact factor: 5.790

8.  Incorporation of glucose analogs by GtfE and GtfD from the vancomycin biosynthetic pathway to generate variant glycopeptides.

Authors:  Heather C Losey; Jiqing Jiang; John B Biggins; Markus Oberthür; Xiang Yang Ye; Steven D Dong; Daniel Kahne; Jon S Thorson; Christopher T Walsh
Journal:  Chem Biol       Date:  2002-12

9.  Optimization of culture conditions and scale-up to pilot and plant scales for vancomycin production by Amycolatopsis orientalis.

Authors:  Hyung-Moo Jung; Sang-Yong Kim; Hee-Jung Moon; Deok-Kun Oh; Jung-Kul Lee
Journal:  Appl Microbiol Biotechnol       Date:  2007-10-16       Impact factor: 4.813

Review 10.  A comparative review of the lipoglycopeptides: oritavancin, dalbavancin, and telavancin.

Authors:  Michael T Guskey; Brian T Tsuji
Journal:  Pharmacotherapy       Date:  2010-01       Impact factor: 4.705

View more
  36 in total

1.  A stepwise dechlorination/cross-coupling strategy to diversify the vancomycin 'in-chloride'.

Authors:  Tyler J Wadzinski; Katherine D Gea; Scott J Miller
Journal:  Bioorg Med Chem Lett       Date:  2015-12-11       Impact factor: 2.823

2.  Practical silyl protection of ribonucleosides.

Authors:  Thomas P Blaisdell; Sunggi Lee; Pinar Kasaplar; Xixi Sun; Kian L Tan
Journal:  Org Lett       Date:  2013-09-03       Impact factor: 6.005

Review 3.  Asymmetric Iridium-Catalyzed C-C Coupling of Chiral Diols via Site-Selective Redox-Triggered Carbonyl Addition.

Authors:  Inji Shin; Michael J Krische
Journal:  Top Curr Chem       Date:  2016

4.  Natural product synthesis at the interface of chemistry and biology.

Authors:  Jiyong Hong
Journal:  Chemistry       Date:  2014-07-10       Impact factor: 5.236

Review 5.  Molecular recognition in protein modification with rhodium metallopeptides.

Authors:  Zachary T Ball
Journal:  Curr Opin Chem Biol       Date:  2015-01-10       Impact factor: 8.822

6.  Regiodivergent Glycosylations of 6-Deoxy-erythronolide B and Oleandomycin-Derived Macrolactones Enabled by Chiral Acid Catalysis.

Authors:  Jia-Hui Tay; Alonso J Argüelles; Matthew D DeMars; Paul M Zimmerman; David H Sherman; Pavel Nagorny
Journal:  J Am Chem Soc       Date:  2017-06-19       Impact factor: 15.419

7.  Fixing the Unfixable: The Art of Optimizing Natural Products for Human Medicine.

Authors:  Audrey E Yñigez-Gutierrez; Brian O Bachmann
Journal:  J Med Chem       Date:  2019-04-26       Impact factor: 7.446

8.  Pursuit of Noncovalent Interactions for Strategic Site-Selective Catalysis.

Authors:  F Dean Toste; Matthew S Sigman; Scott J Miller
Journal:  Acc Chem Res       Date:  2017-03-21       Impact factor: 22.384

Review 9.  Biological, chemical, and biochemical strategies for modifying glycopeptide antibiotics.

Authors:  Edward Marschall; Max J Cryle; Julien Tailhades
Journal:  J Biol Chem       Date:  2019-10-31       Impact factor: 5.157

Review 10.  Chemo- and site-selective derivatizations of natural products enabling biological studies.

Authors:  Omar Robles; Daniel Romo
Journal:  Nat Prod Rep       Date:  2014-03       Impact factor: 13.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.